INHALATION SCIENCES SWEDEN AB Join Inhalation Sciences AB (ISAB) CEO Manoush Masarrat for a 2-minute company pitch and 20-minute analyst Q&A at the livestreamed Redeye Life Science Day, November 23, 2023.
ISAB has achieved robust growth for sales of its unique, high-precision platform technology and Inhalation Research Services (IRS), with a Q2 revenue increase of 36% compared to the same period last year, and a 500% growth in signed sales orders compared to the same period in the preceding year.
Manoush will be joining a host of other Nordic Life Science executives at the event.
Don't miss the opportunity to learn more about ISAB's recent achievements and developments - explore Life Science Day 2023 here:https://www.redeye.se/events/915984/redeye-life-science-day-2023?tab=attendingcompanies
For more information about Inhalation Sciences, please contact: Manoush Masarrat, CEO E-mail: Manoush.masarrat@inhalation.se Mobile: +46 (0)73 628 9153
Press release in PDF formatAttachments
- Original Link
- Original Document
- Permalink
Disclaimer
Inhalation Sciences Sweden AB published this content on 31 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2023 13:21:48 UTC.
